Source: International Congress 2016 – Clinic of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Morad Nakhleh (Le Plessis Robinson, France), Morad Nakhleh, Raneen Jeries, David Montani, Barbara Girerd, Frédéric Perros, Gilles Garcia, Gérald Simonneau, Elie Fadel, Marc Humbert, Hossam Haick, Sylvia Cohen-Kaminsly. LATE-BREAKING ABSTRACT: Vascular endothelial cells in pulmonary arterial hypertension express a unique spectrum of volatile organic compounds. Eur Respir J 2016; 48: Suppl. 60, 257

Member's Comments

No comment yet.

Related content which might interest you: Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 LATE-BREAKING ABSTRACT: A novel and translatable cell assay for the study of vascular signalling in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 LATE-BREAKING ABSTRACT: Pulmonary gas exchange differentiates pulmonary arterial from venous hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 LATE-BREAKING ABSTRACT: Riociguat for the treatment of pulmonary arterial hypertension (PAH): 2-year results from the PATENT-2 long-term extension Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Endothelial microparticles and progenitor cells in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Changes in red blood cell membrane structure in pulmonary arterial hypertension Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016 LSC 2014 abstract - Combined effects of inflammatory mediators and BMPR2 mutation on pulmonary arterial cell function in a pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling? Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Endothelial cell mechanics are altered in pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Treprostinil prodrugs for pulmonary arterial hypertension evaluated in cAMP profiling studies in live CHO-K1 cells Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014